Abstract
It is ten years since bisphophonates have been used for osteoporosis treatment in Japan, while the number of long term bisphosphonate treatment patients has been increased. Recently atypical femoral fractures or osteonecrosis of jaw have been reported. Although incidence of atypical fractures is very rare compared to the number of the patients under bisphosphonate treatment, these conditions are thought caused by severely suppressed bone turnover by the treatment. If the osteoporotic patients under long term bisphophonates treatment have not high fracture risk, drug holiday should be considered.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
